Verition Fund Management LLC Biocryst Pharmaceuticals Inc Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

A detailed history of Verition Fund Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 39,520 shares of BCRX stock, worth $300,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,520
Previous 142,359 72.24%
Holding current value
$300,352
Previous $879,000 65.87%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.41 - $8.69 $659,197 - $893,670
-102,839 Reduced 72.24%
39,520 $300,000
Q2 2024

Aug 14, 2024
BUY
$4.13 - $6.79 $587,942 - $966,617
142,359 New
142,359 $879,000
Q4 2023

Feb 14, 2024
SELL
$4.98 - $6.77 $87,000 - $118,271
-17,470 Reduced 35.67%
31,510 $188,000
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $122,793 - $144,936
18,300 Added 59.65%
48,980 $346,000
Q2 2023

Aug 14, 2023
BUY
$6.96 - $8.81 $58,464 - $74,004
8,400 Added 37.7%
30,680 $215,000
Q1 2023

May 15, 2023
BUY
$7.94 - $11.84 $176,903 - $263,795
22,280 New
22,280 $185,000
Q2 2022

Aug 15, 2022
SELL
$7.89 - $17.88 $122,397 - $277,372
-15,513 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$11.56 - $19.76 $179,330 - $306,536
15,513 New
15,513 $252,000
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $207,949 - $258,290
-14,634 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.5 - $17.24 $139,023 - $252,290
14,634 New
14,634 $231,000
Q4 2020

Feb 16, 2021
SELL
$3.37 - $8.61 $1.83 Million - $4.67 Million
-541,839 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$3.43 - $5.53 $1.86 Million - $3 Million
541,839 New
541,839 $1.86 Million

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email